English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/124929
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance

AuthorsFrancés, Daniel E.; Motiño, Omar ; Agra, Noelia ; González-Rodríguez, Águeda; Fernández-Alvarez, Ana Julia ; Cucarella, Carme ; Mayoral, Rafael ; Castro-Sánchez, Luis; García-Casarrubios, Ester; Boscá, Lisardo ; Carnovale, Cristina E.; Casado, Marta ; Valverde, Ángela M.; Martín-Sanz, Paloma
Issue Date2015
PublisherAmerican Diabetes Association
CitationDiabetes 64(5): 1522-1531 (2015)
AbstractAccumulation evidence links obesity-induced inflammation as an important contributor to the development of insulin resistance, which plays a key role in the pathophysiology of obesity-related diseases such as type 2 diabetes and nonalcoholic fatty liver disease. Cyclooxygenase (COX)-1 and -2 catalyze the first step in prostanoid biosynthesis. Because adult hepatocytes fail to induce COX-2 expression regardless of the proinflammatory stimuli used, we have evaluated whether this lack of expression under mild proinflammatory conditions might constitute a permissive condition for the onset of insulin resistance. Our results show that constitutive expression of human COX-2 (hCOX-2) in hepatocytes protects against adiposity, inflammation, and, hence, insulin resistance induced by a high-fat diet, as demonstrated by decreased hepatic steatosis, adiposity, plasmatic and hepatic triglycerides and free fatty acids, increased adiponectin-to-leptin ratio, and decreased levels of proinflammatory cytokines, together with an enhancement of insulin sensitivity and glucose tolerance. Furthermore, hCOX-2 transgenic mice exhibited increased whole-body energy expenditure due in part by induction of thermogenesis and fatty acid oxidation. The analysis of hepatic insulin signaling revealed an increase in insulin receptor-mediated Akt phosphorylation in hCOX-2 transgenic mice. In conclusion, our results point to COX-2 as a potential therapeutic target against obesity-associated metabolic dysfunction.
URIhttp://hdl.handle.net/10261/124929
DOI10.2337/db14-0979
Identifiersdoi: 10.2337/db14-0979
issn: 0012-1797
e-issn: 1939-327X
Appears in Collections:(IBV) Artículos
(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.